Posted in | News | Nanomedicine | Nanobusiness

MagForce Announces Installation of NanoActivator at Cologne University Hospital

MagForce AG, a leading medical device company in the field of nanomedicine focused on oncology, today announced the installation of the fourth NanoActivator(R).

The device was installed at Cologne University Hospital to provide NanoTherm(TM) therapy for the treatment of brain cancers and Cologne University Hospital will participate in MagForce's post marketing study. Since NanoTherm(TM) therapy has the European CE mark (in the 27 EU countries), commercial patients can also be treated in Cologne. NanoActivator(R) devices are now available for treatment of patients at the University Medical Centers in Cologne, Kiel, Münster and Berlin.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.